comparemela.com
Home
Live Updates
Owl Therapeutics Enters a Strategic Clinical Collaboration W
Owl Therapeutics Enters a Strategic Clinical Collaboration W
Owl Therapeutics Enters a Strategic Clinical Collaboration With Abliva to Advance NeuroSTAT® (OWL-1410) for Traumatic Brain Injury
/PRNewswire/ -- Owl Therapeutics, a wholly-owned subsidiary of Gryphon Bio, today announced a global licensing and collaboration agreement with Abliva AB of...
Related Keywords
Stockholm ,
Sweden ,
Williame Haskins ,
Franklin Okumu ,
Abliva Neuro ,
Todd Kilbaugh ,
Mitochondrial Health ,
Wisdom For Brain Health ,
Owl Therapeutics ,
Gryphon Bio ,
Chief Executive Officer ,
Fast Track ,
Chief Technology Officer ,
Scientific Advisory Board ,
Unlocking Wisdom ,
Delivering Mitochondrial ,
Nasdaq Stockholm ,